Strategy and research progress of lipid management after coronary artery bypass grafting
- VernacularTitle:冠状动脉旁路移植术后血脂管理策略及研究进展
- Author:
Fangzhou LI
1
;
Xiaoting SU
1
;
Heng ZHANG
2
;
Zhe ZHENG
2
Author Information
1. National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Beijing, 100037, P. R. China
2. 1. National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Beijing, 100037, P. R. China；2.Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P. R. China
- Publication Type:Journal Article
- Keywords:
Coronary heart disease;
coronary artery bypass grafting;
dyslipidemia;
lipid-lowering therapy;
secondary prevention;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(11):1532-1539
- CountryChina
- Language:Chinese
-
Abstract:
Patients undergoing coronary artery bypass grafting (CABG) belong to the very high-risk group of atherosclerotic cardiovascular disease. Although CABG gets advantages in relieving symptoms and improving long-term outcomes, a significant risk of cardiovascular adverse events after surgery still exists and standardized secondary prevention is needed. Lipid management plays a critical role as a secondary preventive strategy in CABG. However, lipid management of CABG patients in real clinical setting is inadequate, including lack of standardized lipid-lowering strategy, low goal attainment rate, as well as poor long-term medication adherence. In recent years, a series of clinical trials have provided a lot of groundbreaking new evidence for lipid management in patients with cardiovascular diseases which offers new strategies together with objectives of lipid-lowering and comprehensive management for patients undergoing CABG. This article reviews the strategy and research progress of lipid management after CABG, aiming to provide objective reference for clinical treatment.
